Skip to main content
. Author manuscript; available in PMC: 2016 Feb 23.
Published in final edited form as: Br J Dermatol. 2013 Aug;169(2):428–433. doi: 10.1111/bjd.12383

Table 2.

Demographic characteristics, family history of autoimmune disease, lesion distribution, and treatment modalities distributed by lupus erythematosus (LE) subtype

CCLE SCLE ACLE LE-Nonspecific Total Childhood Cutaneous LE Neonatal LE
N 17 6 13 15 38 15
Sex
 Female (%) 9 (52.9) 5 (83.3) 12 (92.3) 10 (66.7) 26 (68.4) 9 (60.0)
 Male (%) 8 (47.1) 1 (16.7) 1 (7.7) 5 (33.3) 12 (31.6) 6 (40.0)
 Female:male ratio 1.1:1 5:1 12:1 2:1 2.2:1 1.5:1
Race
 Black (%) 6 (35.3) 3 (50.0) 5 (38.5) 8 (53.3) 17 (44.7) 6 (40.0)
 Asian (%) 2 (11.8) 0 1 (7.7) 0 3 (7.9) 0
 Caucasian (%) 5 (29.4) 3 (50.0) 6 (46.2) 6 (40.0) 13 (34.2) 8 (53.3)
 Latino (%) 4 (23.5) 0 1 (7.7) 1 (6.7) 5 (13.2) 0
 Unspecified (%) 0 0 0 0 0 1 (6.7)
Mean age at onset (Median, Range) 9.9 years (11, 2–15) 11.3 years (12, 2–16) 13.6 years (13, 10–18) 13.5 years (13, 9–18) 11.6 years (12.5, 2–17) 3.8 weeks (4, 0–8)
Family history
 Immediate (%) 3 (17.6) 0 4 (30.8) 8 (53.3) 10 (26.3) 13 (86.7)
 Distant (%) 1 (5.9) 3 (50.0) 5 (38.5) 3 (20.0) 7 (18.4) 0
 None (%) 13 (76.5) 3 (50.0) 4 (30.8) 4 (26.7) 21 (55.3) 2 (13.3)
Distribution
 Head (%) 15 (88.2) 6 (100) 11 (84.6) 8 (53.3) 35 (92.1) 15 (100)
 Trunk (%) 3 (17.6) 4 (66.7) 4 (30.8) 7 (46.7) 12 (31.6) 6 (40.0)
 Upper extremities (%) 7 (41.2) 5 (83.3) 4 (30.8) 10 (66.7) 20 (52.6) 3 (20.0)
 Lower extremities (%) 3 (17.6) 4 (66.7) 3 (23.1) 7 (46.7) 10 (26.3) 4 (26.7)
 Genitals (%) 0 0 0 1 (6.7) 1 (2.6) 1 (6.7)
Treatment
 Topical (%) 15 (88.2) 4 (66.7) 9 (69.2) 7 (46.7) 26 (68.4) 11 (73.3)
 Systemic (%) 12 (70.6) 6 (100) 13 (100) 15 (100) 33 (86.8) 0

LE, lupus erythematosus; CCLE, chronic cutaneous lupus erythematosus; SCLE, subacute cutaneous lupus erythematosus; ACLE, acute cutaneous lupus erythematosus